Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E.

Lefèvre M, Felmlee DJ, Parnot M, Baumert TF, Schuster C.

PLoS One. 2014 Apr 21;9(4):e95550. doi: 10.1371/journal.pone.0095550. eCollection 2014.

2.

Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.

Andréo U, Maillard P, Kalinina O, Walic M, Meurs E, Martinot M, Marcellin P, Budkowska A.

Cell Microbiol. 2007 Oct;9(10):2445-56. Epub 2007 May 21.

PMID:
17517063
3.

Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.

Jiang J, Wu X, Tang H, Luo G.

PLoS One. 2013 Jul 2;8(7):e67982. doi: 10.1371/journal.pone.0067982. Print 2013.

4.

Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.

Xu Y, Martinez P, Séron K, Luo G, Allain F, Dubuisson J, Belouzard S.

J Virol. 2015 Apr;89(7):3846-58. doi: 10.1128/JVI.03647-14. Epub 2015 Jan 21.

5.

Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins.

Lee JY, Acosta EG, Stoeck IK, Long G, Hiet MS, Mueller B, Fackler OT, Kallis S, Bartenschlager R.

J Virol. 2014 Nov;88(21):12422-37. doi: 10.1128/JVI.01660-14. Epub 2014 Aug 13.

6.

Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.

Hepatology. 2012 Aug;56(2):484-91. doi: 10.1002/hep.25665. Epub 2012 Jul 2.

7.

Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.

Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G.

J Virol. 2012 Jul;86(13):7256-67. doi: 10.1128/JVI.07222-11. Epub 2012 Apr 24.

8.

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.

Yang Z, Wang X, Chi X, Zhao F, Guo J, Ma P, Zhong J, Niu J, Pan X, Long G.

J Virol. 2016 Oct 14;90(21):9632-9643. doi: 10.1128/JVI.01353-16. Print 2016 Nov 1. Erratum in: J Virol. 2017 Nov 30;91(24):.

9.

Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Hueging K, Doepke M, Vieyres G, Bankwitz D, Frentzen A, Doerrbecker J, Gumz F, Haid S, Wölk B, Kaderali L, Pietschmann T.

J Virol. 2014 Feb;88(3):1433-46. doi: 10.1128/JVI.01815-13. Epub 2013 Oct 30.

10.

Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.

Zhang F, Sodroski C, Cha H, Li Q, Liang TJ.

Gastroenterology. 2017 Jan;152(1):257-270.e7. doi: 10.1053/j.gastro.2016.09.033. Epub 2016 Sep 30.

12.
13.

Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Calattini S, Fusil F, Mancip J, Dao Thi VL, Granier C, Gadot N, Scoazec JY, Zeisel MB, Baumert TF, Lavillette D, Dreux M, Cosset FL.

J Biol Chem. 2015 Sep 18;290(38):23173-87. doi: 10.1074/jbc.M115.662999. Epub 2015 Jul 29.

14.

Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.

Fauvelle C, Felmlee DJ, Crouchet E, Lee J, Heydmann L, Lefèvre M, Magri A, Hiet MS, Fofana I, Habersetzer F, Foung SK, Milne R, Patel AH, Vercauteren K, Meuleman P, Zeisel MB, Bartenschlager R, Schuster C, Baumert TF.

Gastroenterology. 2016 Jan;150(1):206-217.e4. doi: 10.1053/j.gastro.2015.09.014. Epub 2015 Sep 25.

PMID:
26404951
15.

Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.

Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, Funami K, Ohsaki Y, Fujimoto T, Takaku H, Wakita T, Baumert TF, Miyanari Y, Shimotohno K.

J Virol. 2010 Nov;84(22):12048-57. doi: 10.1128/JVI.01063-10. Epub 2010 Sep 8.

16.

The Role of ApoE in HCV Infection and Comorbidity.

Gong Y, Cun W.

Int J Mol Sci. 2019 Apr 25;20(8). pii: E2037. doi: 10.3390/ijms20082037. Review.

17.

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor.

Owen DM, Huang H, Ye J, Gale M Jr.

Virology. 2009 Nov 10;394(1):99-108. doi: 10.1016/j.virol.2009.08.037. Epub 2009 Sep 13.

18.

Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.

Weller R, Hueging K, Brown RJP, Todt D, Joecks S, Vondran FWR, Pietschmann T.

J Virol. 2017 Aug 24;91(18). pii: e00422-17. doi: 10.1128/JVI.00422-17. Print 2017 Sep 15.

19.

Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.

Jung BK, Kim HR, Park GN, Luo G, Chang KS.

J Microbiol. 2016 Jun;54(6):451-8. doi: 10.1007/s12275-016-6099-3. Epub 2016 May 27.

PMID:
27225463
20.

Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.

Futamura M, Dhanasekaran P, Handa T, Phillips MC, Lund-Katz S, Saito H.

J Biol Chem. 2005 Feb 18;280(7):5414-22. Epub 2004 Dec 6.

Supplemental Content

Support Center